|4Sep 13, 8:08 PM ET

Coelho Mary Theresa 4

4 · AzurRx BioPharma, Inc. · Filed Sep 13, 2021

Insider Transaction Report

Form 4
Period: 2021-09-09
Transactions
  • Award

    Stock option (right to buy)

    2021-09-09+10,31010,310 total
    Exercise: $0.64Exp: 2031-09-09Common stock, par value $0.0001 per share (10,310 underlying)
Footnotes (2)
  • [F1]The number of derivative securities reported has not been adjusted to reflect the 10-for-1 reverse stock split of AzurRx BioPharma, Inc. common stock that occurred on September 13, 2021.
  • [F2]The stock option vests on December 31, 2021.

Documents

1 file
  • 4
    form4-09132021_050904.xmlPrimary